Pituitary Adenoma on 18F-Fluciclovine PET/CT

被引：7
作者：
Wang, Jiaqiong [1 ]
Foley, Mark [1 ]
Kuker, Russ [1 ]
机构：
[1] Jackson Mem Hosp, Miller Sch Med, Dept Radiol, Univ Miami Hosp,Div Nucl Med, Miami, FL 33136 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2020年 / 45卷 / 01期
关键词：
pituitary adenoma; prostate cancer; MRI; F-18-Fluciclovine PET/CT; ACID; RADIOTRACER;
D O I：
10.1097/RLU.0000000000002777
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 69-year-old man presented with lower urinary tract symptoms and prostate biopsy showed prostate cancer. F-18-Fluciclovine PET/CT revealed abnormal increased radiotracer uptake within the prostate gland, and multiple osseous structures, suspicious for tumoral involvement. Incidentally, an expansile soft tissue density mass arising from sella turcica demonstrated increased radiotracer activity. MRI showed a lobulated enhancing mass centered in the sella and eroding into the sphenoid sinus. The differential diagnosis includes pituitary macroadenoma versus prostate cancer metastasis. The tumor was resected and the pathological diagnosis was pituitary adenoma.
引用
收藏
页码：E65 / E66
页数：2
相关论文
共 10 条
  • [1] 18F-Fluciclovine PET/CT Detection of Recurrent Prostate Carcinoma in Patients With Serum PSA ≤ 1 ng/mL After Definitive Primary Treatment
    England, Joseph R.
    Paluch, Jeremy
    Ballas, Leslie K.
    Jadvar, Hossein
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (03) : e128 - e132
  • [2] Multimodal 18F-Fluciclovine PET/MRI and Ultrasound-Guided Neurosurgery of an Anaplastic Oligodendroglioma
    Karlberg, Anna
    Berntsen, Erik Magnus
    Johansen, Hakon
    Myrthue, Mariane
    Skjulsvik, Anne Jarstein
    Reinertsen, Ingerid
    Esmaeili, Morteza
    Dai, Hong Yan
    Xiao, Yiming
    Rivaz, Hassan
    Borghammer, Per
    Solheim, Ole
    Eikenes, Live
    [J]. WORLD NEUROSURGERY, 2017, 108 : 989.e1 - 989.e8
  • [3] Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors
    Kondo, Akihide
    Ishii, Hisato
    Aoki, Shigeki
    Suzuki, Masaru
    Nagasawa, Hidekazu
    Kubota, Kazuo
    Minamimoto, Ryogo
    Arakawa, Atsushi
    Tominaga, Masato
    Arai, Hajime
    [J]. ANNALS OF NUCLEAR MEDICINE, 2016, 30 (09) : 608 - 618
  • [4] Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and L-[methyl-11C]methionine in human glioma cell lines
    Ono, Masahiro
    Oka, Shuntaro
    Okudaira, Hiroyuki
    Schuster, David M.
    Goodman, Mark M.
    Kawai, Keiichi
    Shirakami, Yoshifumi
    [J]. BRAIN RESEARCH, 2013, 1535 : 24 - 37
  • [5] [18F]Fluciclovine PET discrimination between high- and low-grade gliomas
    Parent, Ephraim E.
    Benayoun, Marc
    Ibeanu, Ijeoma
    Olson, Jeffrey J.
    Hadjipanayis, Constantinos G.
    Brat, Daniel J.
    Adhikarla, Vikram
    Nye, Jonathon
    Schuster, David M.
    Goodman, Mark M.
    [J]. EJNMMI RESEARCH, 2018, 8
  • [6] Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
    Parent, Ephraim E.
    Schuster, David M.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 733 - 739
  • [7] Fluciclovine, Anti-1-Amino-3-[18F]-Fluorocyclobutane-1-Carboxylic Acid: A Novel Radiotracer for Meningioma
    Quoc-Bao Duy Nguyen
    Amato, Robert
    Riascos, Roy
    Bellester, Leomar
    Tendon, Nitin
    Blanco, Angel
    Esquenazi, Yoshua
    [J]. WORLD NEUROSURGERY, 2018, 119 : 132 - 136
  • [8] Schuster DM, 2007, J NUCL MED, V48, P56
  • [9] Shoup TM, 1999, J NUCL MED, V40, P331
  • [10] Tsuyuguchi Naohiro, 2017, Asia Ocean J Nucl Med Biol, V5, P85, DOI 10.22038/aojnmb.2017.8843
1